(MTSI) MACOM Technology Solutions - Overview
Stock: Amplifiers, Switches, Diodes, RF, Microwave, Photonic
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 48.1% |
| Relative Tail Risk | -5.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.34 |
| Alpha | 49.95 |
| Character TTM | |
|---|---|
| Beta | 1.709 |
| Beta Downside | 1.468 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.09% |
| CAGR/Max DD | 1.30 |
Description: MTSI MACOM Technology Solutions January 02, 2026
MACOM Technology Solutions Holdings (NASDAQ: MTSI) designs and manufactures analog semiconductor components that span the RF, microwave, millimeter-wave, and photonic spectra. Its catalog includes standard and custom integrated circuits, multi-chip modules, diodes, amplifiers, switches, and complete subsystems that are embedded in wireless base stations, optical transport gear, radar, satellite links, medical imaging, and test-and-measurement equipment.
The firm’s end-markets are broadly grouped into carrier infrastructure (long-haul/metro, 5G/6G, satellite and PON networks), industrial & defense (radar, electronic warfare, secure data links), and data-center/enterprise applications. Sales are executed through a mix of direct engineering teams, independent reps, and global distributors across the U.S., China, Japan, Singapore, South Korea, Taiwan, and other regions.
Key recent metrics: 2023 revenue reached approximately $1.2 billion, up ~9 % YoY, driven by a 15 % surge in 5G RF front-end shipments; GAAP EPS was $0.34, reflecting disciplined cost control despite a tighter semiconductor supply chain. The analog-RF segment now represents roughly 55 % of total sales, underscoring the sector’s reliance on continued 5G rollout and emerging 6G research funding.
Macro drivers that will shape MACOM’s outlook include the global acceleration of 5G deployments (projected to add $150 billion in RF component spend through 2027), rising defense budgets in the U.S. and NATO allies (which boost demand for high-frequency radar and electronic-countermeasure modules), and the ongoing data-center expansion that fuels higher-frequency optical transceivers.
For a deeper quantitative assessment, you might explore ValueRay’s analyst toolkit to see how these trends translate into valuation scenarios.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 162.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.08 > 1.0 |
| NWC/Revenue: 88.31% < 20% (prev 89.81%; Δ -1.50% < -1%) |
| CFO/TA 0.10 > 3% & CFO 211.6m > Net Income 162.1m |
| Net Debt (448.0m) to EBITDA (262.4m): 1.71 < 3 |
| Current Ratio: 3.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.7m) vs 12m ago 5.41% < -2% |
| Gross Margin: 54.46% > 18% (prev 0.52%; Δ 5395 % > 0.5%) |
| Asset Turnover: 51.69% > 50% (prev 42.88%; Δ 8.81% > 0%) |
| Interest Coverage Ratio: 33.58 > 6 (EBITDA TTM 262.4m / Interest Expense TTM 5.85m) |
Altman Z'' 2.92
| A: 0.43 (Total Current Assets 1.21b - Total Current Liabilities 304.5m) / Total Assets 2.11b |
| B: -0.09 (Retained Earnings -191.3m / Total Assets 2.11b) |
| C: 0.10 (EBIT TTM 196.3m / Avg Total Assets 1.97b) |
| D: -0.25 (Book Value of Equity -186.6m / Total Liabilities 752.4m) |
| Altman-Z'' Score: 2.92 = A |
Beneish M -2.69
| DSRI: 1.35 (Receivables 160.1m/91.8m, Revenue 1.02b/790.6m) |
| GMI: 0.95 (GM 54.46% / 51.53%) |
| AQI: 0.85 (AQ_t 0.32 / AQ_t-1 0.37) |
| SGI: 1.29 (Revenue 1.02b / 790.6m) |
| TATA: -0.02 (NI 162.1m - CFO 211.6m) / TA 2.11b) |
| Beneish M-Score: -2.69 (Cap -4..+1) = A |
What is the price of MTSI shares?
Over the past week, the price has changed by +3.20%, over one month by +40.68%, over three months by +32.20% and over the past year by +92.15%.
Is MTSI a buy, sell or hold?
- StrongBuy: 8
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MTSI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 255.7 | 8.4% |
| Analysts Target Price | 255.7 | 8.4% |
| ValueRay Target Price | 357 | 51.4% |
MTSI Fundamental Data Overview February 08, 2026
P/E Forward = 56.8182
P/S = 17.3334
P/B = 13.0758
P/EG = 0.83
Revenue TTM = 1.02b USD
EBIT TTM = 196.3m USD
EBITDA TTM = 262.4m USD
Long Term Debt = 339.9m USD (from longTermDebt, last quarter)
Short Term Debt = 160.6m USD (from shortTermDebt, last quarter)
Debt = 567.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 448.0m USD (from netDebt column, last quarter)
Enterprise Value = 17.49b USD (17.69b + Debt 567.7m - CCE 768.5m)
Interest Coverage Ratio = 33.58 (Ebit TTM 196.3m / Interest Expense TTM 5.85m)
EV/FCF = 131.8x (Enterprise Value 17.49b / FCF TTM 132.7m)
FCF Yield = 0.76% (FCF TTM 132.7m / Enterprise Value 17.49b)
FCF Margin = 13.00% (FCF TTM 132.7m / Revenue TTM 1.02b)
Net Margin = 15.88% (Net Income TTM 162.1m / Revenue TTM 1.02b)
Gross Margin = 54.46% ((Revenue TTM 1.02b - Cost of Revenue TTM 464.8m) / Revenue TTM)
Gross Margin QoQ = 55.88% (prev 54.61%)
Tobins Q-Ratio = 8.31 (Enterprise Value 17.49b / Total Assets 2.11b)
Interest Expense / Debt = 0.30% (Interest Expense 1.70m / Debt 567.7m)
Taxrate = 1.66% (822.0k / 49.6m)
NOPAT = 193.1m (EBIT 196.3m * (1 - 1.66%))
Current Ratio = 3.96 (Total Current Assets 1.21b / Total Current Liabilities 304.5m)
Debt / Equity = 0.42 (Debt 567.7m / totalStockholderEquity, last quarter 1.35b)
Debt / EBITDA = 1.71 (Net Debt 448.0m / EBITDA 262.4m)
Debt / FCF = 3.38 (Net Debt 448.0m / FCF TTM 132.7m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.21% (Net Income 162.1m / Total Assets 2.11b)
RoE = 12.60% (Net Income TTM 162.1m / Total Stockholder Equity 1.29b)
RoCE = 12.07% (EBIT 196.3m / Capital Employed (Equity 1.29b + L.T.Debt 339.9m))
RoIC = 10.81% (NOPAT 193.1m / Invested Capital 1.79b)
WACC = 11.84% (E(17.69b)/V(18.26b) * Re(12.21%) + D(567.7m)/V(18.26b) * Rd(0.30%) * (1-Tc(0.02)))
Discount Rate = 12.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 1.38%
[DCF Debug] Terminal Value 65.44% ; FCFF base≈148.9m ; Y1≈149.5m ; Y5≈159.5m
Fair Price DCF = 15.41 (EV 1.60b - Net Debt 448.0m = Equity 1.16b / Shares 75.0m; r=11.84% [WACC]; 5y FCF grow -0.10% → 2.90% )
EPS Correlation: 49.80 | EPS CAGR: 11.42% | SUE: 4.0 | # QB: 2
Revenue Correlation: 82.53 | Revenue CAGR: 14.19% | SUE: 1.17 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.07 | Chg30d=+0.046 | Revisions Net=+1 | Analysts=16
EPS current Year (2026-09-30): EPS=4.47 | Chg30d=+0.251 | Revisions Net=+2 | Growth EPS=+28.8% | Growth Revenue=+21.0%
EPS next Year (2027-09-30): EPS=5.54 | Chg30d=+0.466 | Revisions Net=+1 | Growth EPS=+24.0% | Growth Revenue=+17.1%